A double-blind, placebo controlled multi-centre study to evaluate the effects of topical Oxytocin on vaginal atrophy in postmenopausal women.
Phase of Trial: Phase II
Latest Information Update: 31 Jan 2017
At a glance
- Drugs Oxytocin (Primary)
- Indications Atrophic vaginitis
- Focus Therapeutic Use
- Sponsors Peptonic Medical
- 31 Jan 2017 Last checked against ClinicalTrials.gov record.
- 16 Nov 2011 Status changed from active, no longer recruiting to completed as reported by European Clinical Trials Database record.
- 15 Sep 2011 Additional trial identifiers (NCT01432470, OxyPeP001), trial status (completed) and trial centres identified as reported by ClinicalTrials.gov.